Literature DB >> 23419590

Stimulated nitric oxide production and arginine deficiency in children with cystic fibrosis with nutritional failure.

Mariëlle P K J Engelen1, Gulnur Com, Yvette C Luiking, Nicolaas E P Deutz.   

Abstract

OBJECTIVE: To determine whether upregulated whole body de novo arginine synthesis and protein breakdown are present as a compensatory mechanism to meet the increased demand for arginine and nitric oxide (NO) production in pediatric patients with cystic fibrosis (CF) and nutritional failure. STUDY
DESIGN: In 16 children with CF, studied at the end of antibiotic treatment for a pulmonary exacerbation, and 17 healthy controls, whole body arginine, citrulline (Cit), and protein turnover were assessed by stable isotope methodology and de novo arginine synthesis, arginine clearance, NO synthesis, protein synthesis and breakdown, and net protein balance were calculated. The plasma isotopic enrichments and amino acid concentrations were measured by liquid chromatography-tandem mass spectrometry.
RESULTS: Increased arginine clearance was found in patients with CF (P < .001), whereas whole body NO production rate and plasma arginine levels were not different. Whole body arginine production (P < .001), de novo arginine synthesis, and protein breakdown and synthesis (P < .05) were increased in patients with CF, but net protein balance was comparable. Patients with CF with nutritional failure (n = 7) had significantly higher NO production (P < .05), de novo arginine synthesis, Cit production (P < .001), and plasma Cit concentration (P < .05) and lower plasma arginine concentration (P < .05) than those without nutritional failure (n = 9).
CONCLUSIONS: Nutritional failure in CF is associated with increased NO production. However, up-regulation of de novo arginine synthesis and Cit production was not sufficient to meet the increased arginine needs leading to arginine deficiency.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  ADMA; Arg; Arginine; Asymmetric dimethyl arginine; CF; Cit; Citrulline; Cystic fibrosis; FEV(1); FFM; FM; Fat mass; Fat-free mass; FeNO; Forced expiratory volume in 1 second; Fractional exhaled nitric oxide; NO; Nitric oxide; Orn; Ornithine; WbRa; Whole body rate of appearance

Mesh:

Substances:

Year:  2013        PMID: 23419590      PMCID: PMC3661742          DOI: 10.1016/j.jpeds.2013.01.005

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  28 in total

Review 1.  Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization.

Authors:  J L Boucher; C Moali; J P Tenu
Journal:  Cell Mol Life Sci       Date:  1999-07       Impact factor: 9.261

2.  Infected chronic wounds show different local and systemic arginine conversion compared with acute wounds.

Authors:  Iris B J G Debats; Darren Booi; Nicolaas E P Deutz; Wim A Buurman; Willy D Boeckx; Rene R W J van der Hulst
Journal:  J Surg Res       Date:  2006-04-21       Impact factor: 2.192

3.  Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis.

Authors:  Hartmut Grasemann; Fionn Kurtz; Felix Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2006-04-20       Impact factor: 21.405

4.  Measurement of amino acid isotope enrichment by liquid chromatography mass spectroscopy after derivatization with 9-fluorenylmethylchloroformate.

Authors:  Hans M H van Eijk; Dennis P L Suylen; Cornelis H C Dejong; Yvette C Luiking; Nicolaas E P Deutz
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-05-29       Impact factor: 3.205

5.  Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis.

Authors:  Hartmut Grasemann; Suhail Al-Saleh; Jeremy A Scott; Darakhshanda Shehnaz; Anne Mehl; Reshma Amin; Mahroukh Rafii; Paul Pencharz; Jaques Belik; Felix Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2011-01-28       Impact factor: 21.405

6.  Increased arginase activity in cystic fibrosis airways.

Authors:  Hartmut Grasemann; Raphael Schwiertz; Sonja Matthiesen; Kurt Racké; Felix Ratjen
Journal:  Am J Respir Crit Care Med       Date:  2005-09-15       Impact factor: 21.405

7.  Enteral nutrition for patients with cystic fibrosis: comparison of a semi-elemental and nonelemental formula.

Authors:  J M Erskine; C D Lingard; M K Sontag; F J Accurso
Journal:  J Pediatr       Date:  1998-02       Impact factor: 4.406

8.  Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness.

Authors:  Herman Meurs; Sue McKay; Harm Maarsingh; Marco A M Hamer; Lejla Macic; Niek Molendijk; Johan Zaagsma
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

9.  Reduced citrulline production in sepsis is related to diminished de novo arginine and nitric oxide production.

Authors:  Yvette C Luiking; Martijn Poeze; Graham Ramsay; Nicolaas E P Deutz
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

Review 10.  Regulation of nitric oxide production in health and disease.

Authors:  Yvette C Luiking; Mariëlle P K J Engelen; Nicolaas E P Deutz
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-01       Impact factor: 4.294

View more
  8 in total

1.  Major surgery diminishes systemic arginine availability and suppresses nitric oxide response to feeding in patients with early stage breast cancer.

Authors:  Mariëlle P K J Engelen; V Suzanne Klimberg; Arianna Allasia; Nicolaas E P Deutz
Journal:  Clin Nutr       Date:  2017-08-05       Impact factor: 7.324

Review 2.  Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis.

Authors:  Mariëlle P K J Engelen; Gulnur Com; Nicolaas E P Deutz
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2014-11       Impact factor: 4.294

3.  Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease.

Authors:  Renate Jonker; Nicolaas Ep Deutz; Marcia L Erbland; Paula J Anderson; Mariëlle Pkj Engelen
Journal:  Am J Clin Nutr       Date:  2016-05-04       Impact factor: 7.045

4.  New stable isotope method to measure protein digestibility and response to pancreatic enzyme intake in cystic fibrosis.

Authors:  M P K J Engelen; G Com; P J Anderson; N E P Deutz
Journal:  Clin Nutr       Date:  2013-11-09       Impact factor: 7.324

5.  Acute ingestion of citrulline stimulates nitric oxide synthesis but does not increase blood flow in healthy young and older adults with heart failure.

Authors:  Il-Young Kim; Scott E Schutzler; Amy Schrader; Horace J Spencer; Gohar Azhar; Nicolaas E P Deutz; Robert R Wolfe
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-10-06       Impact factor: 4.310

6.  Immunonutrition in patients with cyctic fibrosis leads to drop of serum amyloid A and increase of oxidative stress.

Authors:  Ondrej Hloch; Jiri Charvat; Libor Fila; Havlin Jan
Journal:  J Clin Biochem Nutr       Date:  2017-02-24       Impact factor: 3.114

7.  Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results.

Authors:  Folke Brinkmann; Beatrice Hanusch; Manfred Ballmann; Sebene Mayorandan; Alexander Bollenbach; Kristine Chobanyan-Jürgens; Kathrin Jansen; Anjona Schmidt-Choudhury; Nico Derichs; Dimitrios Tsikas; Thomas Lücke
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

8.  Local and Systemic Alterations of the L-Arginine/Nitric Oxide Pathway in Sputum, Blood, and Urine of Pediatric Cystic Fibrosis Patients and Effects of Antibiotic Treatment.

Authors:  Beatrice Hanusch; Folke Brinkmann; Sebene Mayorandan; Kristine Chobanyan-Jürgens; Anna Wiemers; Kathrin Jansen; Manfred Ballmann; Anjona Schmidt-Choudhury; Alexander Bollenbach; Nico Derichs; Dimitrios Tsikas; Thomas Lücke
Journal:  J Clin Med       Date:  2020-11-24       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.